BioSpace News Archive

Light E.N.T. is seeking volunteers for Phase 3 of the ENLIGHTEN I clinical research study.

The global pharmaceutical company Adalvo announced the acquisition of its first branded product, Onsolis® after concluding a deal with a reputable US based specialty pharmaceutical Company, that originally owned the product.

CURE Pharmaceutical Holding Corp., a proprietary platform technology company, announced the appointment of Gerald Bagg to its board of directors.

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced the appointment of Niall Condon as president of its Manufacturing Division, with immediate effect.

APIE Therapeutics, a preclinical pharmaceutical company pioneering novel and proprietary anti-fibrotic drugs that target the apelin receptor, presented results from in vitro and in vivo studies supporting the potential of APT-101 as a therapeutic for interstitial lung disease, including those cases associated with systemic sclerosis.

According to report study, the global exosome technologies market valued at US$ 31 Mn in 2020 and projected to hit US$ 300 million by 2030, expanding growth at a CAGR of 23.5% from 2021 to 2030.

According to latest report, the global hemoglobin feed market reached value at US$ 217 Mn in 2020 and projected to hit around US$ 340 million by 2030. Rise in usage of hemoglobin powder as a replacement for fish meal is projected to drive the global hemoglobin feed market

As per Vision research Reports, the global dystrophic epidermolysis bullosa treatment market size is predicted to hit around US$ 715 million by 2030 from valued US$ 415 Mn in 2020, expanding growth at a CAGR of 5.1% from 2022 to 2030.

The latest market analysis report published by Reports and Data, titled ‘Global Genital Herpes Treatment Market – Forecast to 2030,’ thoroughly examines the Genital Herpes Treatment industry to provide essential data & information for the targeted readers.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) today reported financial results and provided a business update for the second quarter ended June 30, 2022.